NLRP3 and cryopyrin-associated periodic syndrome: NLRP3-activating mutations cause cryopyrin-associated periodic syndromes (CAPS) of which neonatal-onset multisystem inflammatory disease (NOMID) is the most severe manifestation1, 2.